Colgate-Palmolive Company (NYSE:CL) Stock Has Consensus Price Target of $98.94

Shares of Colgate-Palmolive Company (NYSE:CL) have been assigned an average rating of “Moderate Buy” from the nineteen research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $98.94.

CL has been the subject of several recent research reports. Sanford C. Bernstein reissued a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday, August 13th. Jefferies Financial Group reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, August 3rd. Royal Bank Of Canada reissued an “outperform” rating and issued a $104.00 target price on shares of Colgate-Palmolive in a research note on Tuesday, September 8th. TD Cowen increased their target price on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a report on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Monday, August 3rd.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer owned 64,901 shares in the company, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 161,021 shares of the company’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the transaction, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 175,191 shares of company stock worth $16,110,903 in the last three months. 0.43% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. TD Capital Management LLC grew its position in shares of Colgate-Palmolive by 61.4% in the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock worth $26,000 after buying an additional 124 shares during the last quarter. Parvin Asset Management LLC bought a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $32,000. Park Place Capital Corp lifted its stake in Colgate-Palmolive by 55.5% in the second quarter. Park Place Capital Corp now owns 356 shares of the company’s stock worth $33,000 after acquiring an additional 127 shares during the period. Gould Capital LLC lifted its stake in Colgate-Palmolive by 38.7% in the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after acquiring an additional 115 shares during the period. Finally, Montgomery Financial Services LLC bought a new stake in Colgate-Palmolive in the second quarter valued at $36,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 1.0%

Shares of NYSE CL opened at $84.45 on Tuesday. Colgate-Palmolive has a one year low of $74.54 and a one year high of $99.33. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The firm’s 50 day simple moving average is $89.72 and its two-hundred day simple moving average is $88.81. The stock has a market capitalization of $67.32 billion, a P/E ratio of 33.51, a PEG ratio of 3.98 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same period in the previous year, the business posted $0.92 EPS. The business’s quarterly revenue was up 4.9% on a year-over-year basis. As a group, analysts expect that Colgate-Palmolive will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is presently 84.13%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.